Class IIOngoingVoluntary: Firm initiated
QUTEN RESEARCH INSTITIUTE LLC: food recall H-0418-2026
QUTEN RESEARCH INSTITIUTE LLC of Pine Brook, NJ recalled Qunol, Extra Strength Turmeric Capsule, 1000mg ,HDPE bottle with cap, BIO7771 120 count bottle, BIO7772 120 count… Reason: Mold contamination detected for raw material lots that were produced in July and used in finished goods. The FDA listed it as Class II in its Enforcement Report dated Feb 4, 2026; distribution: Alabama, California, Colorado, Connecticut, Delaware, Florida, Georgia, Iowa, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, North Carolina, New Jersey, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Wisconsin.
Record status as published: Ongoing. openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Qunol, Extra Strength Turmeric Capsule, 1000mg ,HDPE bottle with cap, BIO7771 120 count bottle, BIO7772 120 count bottle ,BIO8281 60 count bottle .
- Product quantity
- Turmeric 1000mg Capsule 60ct Veg., 3276, Turmeric 1000mg Capsule, 120ct Veg. BJ ,10304, Turmeric 1000mg Capsule 120ct Veg. 29160
- Reason for recall
- Mold contamination detected for raw material lots that were produced in July and used in finished goods.
- Codes, lots and dates on the package
- Part Number Lot 12811C120 BIO7771 12811C120BJ BIO7772 12811C60 BIO8281
- Distribution pattern
- The product was distributed to the following states: TX, FL, CA, NC, MI, MN, VA, NJ, MA, OH, IL,AL, CT, TN, NY, MO, PA, RI, SC, OK, GA, MN, WI, NV, IN, IA, CO, LA, NC, OR, KY, DE,
- Recalling firm
- QUTEN RESEARCH INSTITIUTE LLC, Pine Brook, NJ
- Classification
- Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Dec 16, 2025 |
| Classified by the FDA | Jan 23, 2026 |
| Published in the Enforcement Report | Feb 4, 2026 |
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0418-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.